Literature DB >> 22253482

Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.

Dewei Ye1, Francois Y L Li, Karen S L Lam, Huating Li, Weiping Jia, Yu Wang, Kwan Man, Chung Mau Lo, Xiaokun Li, Aimin Xu.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease is an obesity-related chronic liver disorder ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), which may progress to liver fibrosis and cirrhosis.
OBJECTIVE: Tto investigate the role of Toll-like receptor (TLR) 4 in mediating the transition from steatosis to inflammation.
METHODS: ApoE(-/-)/TLR4(mut) mice and ApoE(-/-)/TLR4 wild-type mice (ApoE(-/-)/TLR4-WT) were generated by cross-breeding an ApoE-deficient (ApoE(-/-)) strain with TLR4-mutant (TLR4(mut)) mice, which were fed with high-fat, high-cholesterol (HFHC) diet to induce obesity.
RESULTS: ApoE(-/-)/TLR4-WT mice fed with an HFHC diet for 12 weeks developed typical pathological features of NASH, which is associated with obesity and the metabolic syndrome. By contrast, ApoE(-/-)/TLR4(mut) mice lacking functional TLR4 were resistant to HFHC diet-induced liver inflammation and injury and were less susceptible to the diet-induced production of reactive oxygen species (ROS) and proinflammatory cytokines. In ApoE(-/-)/TLR4-WT mice, X-box binding protein-1 (XBP-1), a transcription factor involved in the unfolded protein responses, was activated in the liver by an HFHC diet, whereas XBP-1 activation was abrogated in ApoE(-/-)/TLR4(mut) mice. In primary rat Kupffer cells, endotoxin induced XBP-1 activation through ROS production, whereas siRNA-mediated knockdown of XBP-1 expression resulted in a marked attenuation in endotoxin-evoked NF-κB activation and cytokine production. Furthermore, adenovirus-mediated expression of dominant negative XBP-1 led to a significant attenuation in HFHC diet-induced liver inflammation and injury in mice.
CONCLUSIONS: These findings support the key role of TLR4 in Kupffer cells in mediating the progression of simple steatosis to NASH, by inducing ROS-dependent activation of XBP-1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22253482     DOI: 10.1136/gutjnl-2011-300269

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  82 in total

Review 1.  Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame.

Authors:  Samar H Ibrahim; Petra Hirsova; Harmeet Malhi; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2015-12-01       Impact factor: 3.199

2.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

3.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

4.  High-fat diet promotes neuronal loss in the myenteric plexus of the large intestine in mice.

Authors:  Evandro José Beraldi; Angélica Soares; Stephanie Carvalho Borges; Aline Cristine da Silva de Souza; Maria Raquel Marçal Natali; Roberto Barbosa Bazotte; Nilza Cristina Buttow
Journal:  Dig Dis Sci       Date:  2014-10-22       Impact factor: 3.199

5.  Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.

Authors:  Binxia Chang; Ming-Jiang Xu; Zhou Zhou; Yan Cai; Man Li; Wei Wang; Dechun Feng; Adeline Bertola; Hua Wang; George Kunos; Bin Gao
Journal:  Hepatology       Date:  2015-07-03       Impact factor: 17.425

6.  Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.

Authors:  Qi Gong; Zhimin Hu; Feifei Zhang; Aoyuan Cui; Xin Chen; Haoyang Jiang; Jing Gao; Xuqing Chen; Yamei Han; Qingning Liang; Dewei Ye; Lei Shi; Y Eugene Chin; Yu Wang; Hui Xiao; Feifan Guo; Yong Liu; Mengwei Zang; Aimin Xu; Yu Li
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

Review 7.  Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.

Authors:  Simon Ducheix; Maria Carmela Vegliante; Gaetano Villani; Nicola Napoli; Carlo Sabbà; Antonio Moschetta
Journal:  Cell Mol Life Sci       Date:  2016-08-13       Impact factor: 9.261

8.  Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.

Authors:  Alexander Wree; Maria Eugenia Inzaugarat; Ariel E Feldstein
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

Review 9.  Microbiota-liver axis in hepatic disease.

Authors:  Benoit Chassaing; Lucie Etienne-Mesmin; Andrew T Gewirtz
Journal:  Hepatology       Date:  2013-11-15       Impact factor: 17.425

10.  Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

Authors:  Qin Pan; Rui-Nan Zhang; Yu-Qin Wang; Rui-Dan Zheng; Yu-Qiang Mi; Wen-Bin Liu; Feng Shen; Guang-Yu Chen; Jia-Fa Lu; Chan-Yan Zhu; Shu-Yi Zhang; Yi-Ming Chen; Wan-Lu Sun; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.